Cordance Medical develops radical therapy for a variety of CNS pathology.
Cordance Medical has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Cordance Medical's investors include National Science Foundation, SmartGateVC, R42 Group, Sonder Capital, Brain Tumor Investment Fund.
Cordance Medical is headquartered in Mountain View, United States.
Cordance Medical develops radical therapy for a variety of CNS pathology.
Cordance Medical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cordance Medical — Funding & Investors." VCBacked, November 24, 2025, https://www.vcbacked.co/company/cordance-medical. Accessed October 30, 2026.
VCBacked. (2025). Cordance Medical — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/cordance-medical
{{cite web |title=Cordance Medical — Funding & Investors |url=https://www.vcbacked.co/company/cordance-medical |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated